Biotechnology/Chemical/Pharmaceutical (BCP) Customer April 17, 2001

United States Patent and Trademark Office

Biotechnology/Chemical/Pharmaceutical Customer Partnership

Crystal Square 4
Arlington, VA 22202

August 7, 2001

 

The Biotechnology and Chemical/Pharmaceutical Customer Partnerships are designed to be a forum to share ideas, experiences, and insights between individual users and the USPTO. The USPTO does not intend to use these customer partnership groups to arrive at any consensus.

 

In the past we have held two separate customer partnership meetings, one in the morning and another in the afternoon. However, to avoid redundancy, we have reorganized the two partnerships into a single, full day event - the Biotechnology/Chemical/Pharmaceutical (BCP) Customer

Partnership . In the morning, we will focus on Office level issues of general interest to all practitioners, such as electronic filing, pre-examination application processing, the petition process, appeals, and others. In the afternoon, we will have four 20 - 40 minute presentations of a more technical nature. We will also be preparing more precise agendas so that those wishing to attend for only specific topics may be assured of the time of the presentation.

The next meeting of the BCP Customer Partnership is scheduled for Tuesday August 7, 2001 from 9:00 AM. to 4:00 PM in Crystal Square 4 Suite 700 located at 1745 Jefferson Davis Highway, Arlington, Virginia. The agenda for this meeting is attached below.

Please contact Cecilia Tsang ( cecilia.tsang@uspto.gov ) at 703-308-0254 or by fax at 703-305-7939, Brian Stanton ( brian.stanton@uspto.gov ) at 703-308-2801, or Sharlamar Taliaferro at 703-306-4094 or by fax 703-305-8002 to confirm your attendance. You may also respond via e-mail to TC1600BCP@uspto.gov .

We look forward to seeing you on the 7 th .

Time Morning Session
9:00 - 9:30
Opening Remarks
John Doll and Jasemine Chambers, Directors, TC 1600
9:30 - 10:00
Practical issues in prosecuting International Applications filed under the Patent Cooperation Treaty (PCT)
TC1600 Special Programs Examiner (SPRE) and PCT Legal/Operation
10:10 - 10:20
Break
10:20 - 10:50
The Pre-examination process...issues and resolutions
Tom Koontz - Director, Office of Initial Patent Examination
10:50 - 11:20
Pre-Grant Publications and Sequence Rule Compliance
John Doll, Director TC 1600
Gary Jones, SPE Art Unit 1655
11:20 - 11:30
Closing Remarks (morning session)
Time Afternoon Session
1:00 - 1:10
Introductory Remarks
1:10- 1:40
Restriction Practice in the Nucleic Acid and Protein Arts
Christopher Low, SPE Art Unit 1653
1:40 - 2:10
TC 1600 Examination Practice - Kit Claims, Means plus Function, and Intended Use Limitations
Long Le, SPE Art Unit 1641
2:10 - 2:30
Break
2:30 - 3:00
TC 1600 Examination Practice in view of In re Ochiai
Johann Richter, SPE Art Unit 1621
3:00 - 3:30
37 C.F.R. §1.105 Requirements for Information - Overview and Practice in PLT Applications
Thurman Page, SPE Art Unit 1615
Bruce Campell, SPE Art Unit 1661
3:30 - 4:00
General Discussion and Closing Remarks